
IX BIOPHARMA LTD. 200405621W
1 Kim Seng Promenade, #14-01 Great World City East Tower, Singapore, 237994
72
198
1 Kim Seng Promenade, #14-01 Great World City East Tower, Singapore, 237994
72
198
BREAKING:
iX Biopharma LTD achieved robust financial performance with significant revenue and gross profit growth, alongside reduced adjusted EBITDA losses. The Group is strategically scaling its wellness business and accelerating its pharmaceutical pipeline's market entry, leveraging unique sublingual technologies.
• Discover how proprietary sublingual technologies are revolutionising drug delivery and market potential
• Explore a key wellness product's strategic expansion into a dynamic longevity market
• Learn about the accelerated commercialisation of pharmaceutical assets through targeted partnerships
LISTEN TO THE PODCAST BELOW:
There will be an AGM on
Event dates:
Meeting Date and Time |
13/10/2023 10:00:00 |
Response Deadline Date |
10/10/2023 10:00:00 |
For more information, click here: IX BIOPHARMA LTD. 2023 AGM